These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 35910798)

  • 41. A natural molecule, urolithin A, downregulates androgen receptor activation and suppresses growth of prostate cancer.
    Dahiya NR; Chandrasekaran B; Kolluru V; Ankem M; Damodaran C; Vadhanam MV
    Mol Carcinog; 2018 Oct; 57(10):1332-1341. PubMed ID: 30069922
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway.
    Singh R; Chandrashekharappa S; Bodduluri SR; Baby BV; Hegde B; Kotla NG; Hiwale AA; Saiyed T; Patel P; Vijay-Kumar M; Langille MGI; Douglas GM; Cheng X; Rouchka EC; Waigel SJ; Dryden GW; Alatassi H; Zhang HG; Haribabu B; Vemula PK; Jala VR
    Nat Commun; 2019 Jan; 10(1):89. PubMed ID: 30626868
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel quinazolinone MJ‑33 induces AKT/mTOR‑mediated autophagy‑associated apoptosis in 5FU‑resistant colorectal cancer cells.
    Ha HA; Chiang JH; Tsai FJ; Bau DT; Juan YN; Lo YH; Hour MJ; Yang JS
    Oncol Rep; 2021 Feb; 45(2):680-692. PubMed ID: 33416156
    [TBL] [Abstract][Full Text] [Related]  

  • 44. SNAI2 modulates colorectal cancer 5-fluorouracil sensitivity through miR145 repression.
    Findlay VJ; Wang C; Nogueira LM; Hurst K; Quirk D; Ethier SP; Staveley O'Carroll KF; Watson DK; Camp ER
    Mol Cancer Ther; 2014 Nov; 13(11):2713-26. PubMed ID: 25249558
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Curcumin Reverses 5-Fluorouracil Resistance by Promoting Human Colon Cancer HCT-8/5-FU Cell Apoptosis and Down-regulating Heat Shock Protein 27 and P-Glycoprotein.
    He WT; Zhu YH; Zhang T; Abulimiti P; Zeng FY; Zhang LP; Luo LJ; Xie XM; Zhang HL
    Chin J Integr Med; 2019 Jun; 25(6):416-424. PubMed ID: 30484020
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chromosomal imbalance maps of human 5FU-resistant colorectal cancer cell lines: implications in the analysis of 5FU-acquired resistance mechanisms.
    Plasencia C; Rooney PH; Taron M; Martinez-Balibrea E; McLeod HL; Abad A
    Int J Oncol; 2003 May; 22(5):945-53. PubMed ID: 12684658
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Andrographis-mediated chemosensitization through activation of ferroptosis and suppression of β-catenin/Wnt-signaling pathways in colorectal cancer.
    Sharma P; Shimura T; Banwait JK; Goel A
    Carcinogenesis; 2020 Oct; 41(10):1385-1394. PubMed ID: 32835374
    [TBL] [Abstract][Full Text] [Related]  

  • 48. FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10.
    Xie T; Geng J; Wang Y; Wang L; Huang M; Chen J; Zhang K; Xue L; Liu X; Mao X; Chen Y; Wang Q; Dai T; Ren L; Yu H; Wang R; Chen L; Chen C; Chu X
    Oncotarget; 2017 Jan; 8(5):8574-8589. PubMed ID: 28051999
    [TBL] [Abstract][Full Text] [Related]  

  • 49. FOXM1/DVL2/Snail axis drives metastasis and chemoresistance of colorectal cancer.
    Yang Y; Jiang H; Li W; Chen L; Zhu W; Xian Y; Han Z; Yin L; Liu Y; Wang Y; Pan K; Zhang K
    Aging (Albany NY); 2020 Dec; 12(23):24424-24440. PubMed ID: 33291076
    [TBL] [Abstract][Full Text] [Related]  

  • 50. FoxO3 reverses 5-fluorouracil resistance in human colorectal cancer cells by inhibiting the Nrf2/TR1 signaling pathway.
    Liu C; Zhao Y; Wang J; Yang Y; Zhang Y; Qu X; Peng S; Yao Z; Zhao S; He B; Mi Q; Zhu Y; Liu X; Zou J; Zhang X; Du Q
    Cancer Lett; 2020 Feb; 470():29-42. PubMed ID: 31811910
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MiR-142-3p functions as a tumor suppressor by targeting CD133, ABCG2, and Lgr5 in colon cancer cells.
    Shen WW; Zeng Z; Zhu WX; Fu GH
    J Mol Med (Berl); 2013 Aug; 91(8):989-1000. PubMed ID: 23619912
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Terpenoids from quinoa reverse drug resistance of colon cancer by upregulating miR-495-3p.
    Feng M; Fan X; Shi J; Shan S; Li S; He S; Ding M; Li Z
    J Sci Food Agric; 2024 Nov; 104(14):8916-8927. PubMed ID: 38962946
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MicroRNA-494 sensitizes colon cancer cells to fluorouracil through regulation of DPYD.
    Chai J; Dong W; Xie C; Wang L; Han DL; Wang S; Guo HL; Zhang ZL
    IUBMB Life; 2015 Mar; 67(3):191-201. PubMed ID: 25873402
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effects of 5-fluorouracil on the proteome of colon cancer cells.
    Marin-Vicente C; Lyutvinskiy Y; Romans Fuertes P; Zubarev RA; Visa N
    J Proteome Res; 2013 Apr; 12(4):1969-79. PubMed ID: 23477467
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The FOXO3-FOXM1 axis: A key cancer drug target and a modulator of cancer drug resistance.
    Yao S; Fan LY; Lam EW
    Semin Cancer Biol; 2018 Jun; 50():77-89. PubMed ID: 29180117
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regorafenib antagonizes BCRP-mediated multidrug resistance in colon cancer.
    Zhang YK; Wang YJ; Lei ZN; Zhang GN; Zhang XY; Wang DS; Al-Rihani SB; Shukla S; Ambudkar SV; Kaddoumi A; Shi Z; Chen ZS
    Cancer Lett; 2019 Feb; 442():104-112. PubMed ID: 30392788
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Drug resistance of bladder cancer cells through activation of ABCG2 by FOXM1.
    Roh YG; Mun MH; Jeong MS; Kim WT; Lee SR; Chung JW; Kim SI; Kim TN; Nam JK; Leem SH
    BMB Rep; 2018 Feb; 51(2):98-103. PubMed ID: 29397866
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Resistance to 5-fluorouracil: The molecular mechanisms of development in colon cancer cells.
    Radenković N; Nikodijević D; Jovankić J; Blagojević S; Milutinović M
    Eur J Pharmacol; 2024 Nov; 983():176979. PubMed ID: 39241942
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of the methylenetetrahydrofolate reductase C677T polymorphism on chemosensitivity of colon and breast cancer cells to 5-fluorouracil and methotrexate.
    Sohn KJ; Croxford R; Yates Z; Lucock M; Kim YI
    J Natl Cancer Inst; 2004 Jan; 96(2):134-44. PubMed ID: 14734703
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Visfatin inhibits colon cancer cell apoptosis and decreases chemosensitivity to 5‑FU by promoting the SDF‑1/CXCR4/Akt axis.
    Zhao Q; Long Y; Cheng W; Huang Y; Li J; Li Y; Li X; Guo X; Li Y; Li G; Gong K; Zhang J
    Int J Oncol; 2022 Jun; 60(6):. PubMed ID: 35506454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.